Quantifying the tendency of therapeutic target proteins to bind promiscuous or selective compounds

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Hu, Ye ^a   Bajorath, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; CHEMOKINE RECEPTOR; DIHYDROOROTATE DEHYDROGENASE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; G PROTEIN COUPLED RECEPTOR; LIGAND; PROTEIN SERINE THREONINE KINASE; PURINERGIC P2Y12 RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; PROTEIN BINDING;

ARTICLE; EQUILIBRIUM CONSTANT; IC50; POLYPHARMACOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN TARGETING; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION;

LIGANDS; POLYPHARMACOLOGY; PROTEIN BINDING; PROTEIN TRANSPORT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84930616579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126838     Document Type: Article

References (12)

1. Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL. Global mapping of pharmacological space. Nat. Biotechnol. 2006; 24: 805-815. PMID: 16841068
2. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 2008; 4: 682-690. doi: 10.1038/nchembio.118 PMID: 18936753
3. Peters JU. Polypharmacology - foe or friend? J. Med. Chem. 2013; 56: 8955-8971. doi: 10.1021/jm400856t PMID: 23919353
4. Anighoro A, Bajorath J, Rastelli G. Polypharmacology: challenges and opportunities in drug discovery. J. Med. Chem. 2014; 57: 7874-7887. doi: 10.1021/jm5006463 PMID: 24946140
5. Jalencas X, Mestres J. On the origins of drug polypharmacology. Med. Chem. Comm. 2013; 4: 80-87.
6. Hu Y, Bajorath J. Compound promiscuity: What can we learn from current data? Drug Discov. Today 2013; 18: 644-650. doi: 10.1016/j.drudis.2013.03.002 PMID: 23524195
7. Hu Y, Bajorath J. How promiscuous are pharmaceutically relevant compounds? A data-driven assessment. AAPS J. 2013; 15: 104-111. doi: 10.1208/s12248-012-9421-y PMID: 23090085
8. Hu Y, Bajorath J. Global assessment of scaffold hopping potential for current pharmaceutical targets. Med. Chem. Comm. 2010; 1: 339-344.
9. Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, et al. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014; 42: D1083-D1090. doi: 10.1093/nar/gkt1031 PMID: 24214965
10. UniProtConsortium. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res. 2012; 40: D142-D148.
11. Bemis GW, Murcko MA. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996; 39: 2887-2893. PMID: 8709122
12. Xu YJ, Johnson M. Using molecular equivalence numbers to visually explore structural features that distinguish chemical libraries. J. Chem. Inf. Comput. Sci. 2002; 42: 912-926. PMID: 12132893